anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Table

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 60,557
Current window 27,331-27,360
Pages 2,019
Rows per page 30
Component: Tableclear collectionreset all
18 30 60

Component

27,331-27,360 of 60,557

filter-aware
29
The slide uses a dot-matrix to visualize market presence by product type and region.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
34
The slide uses media headlines as evidence of the financial risk associated with traditional R&D models.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
51
The table highlights the performance of 'Total Product Sales' across different periods.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
55
The slide uses a table to show the vesting schedule of performance share units (PSUs) based on annualized Total Shareholder Return (TSR).Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
62
The slide uses a bridge-style reconciliation table to justify non-GAAP metrics.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
63
The slide uses a table to contrast GAAP accounting practices with the author's economic view of the company's performance.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
71
Allergan, Inc. (AGN)Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
73
The slide highlights that the analyst's 6-8% growth estimate is a slight discount to management's own projections.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
76
Allergan, Inc. (AGN)Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
77
The slide uses a comparison framework to justify valuation multiples by drawing parallels to a high-performing consumer sector.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
81
The slide outlines the assumptions (10% discount rate, 10-year life, 0-5% growth) and presents a sensitivity table for DCF multiples.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
82
The table uses a weighted average approach based on earnings contribution to derive the base business multiple.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
90
The slide uses a custom qualitative scoring framework represented by pie charts.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
93
The slide uses a before-after framing to demonstrate that realized synergies consistently exceeded initial announcements.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
94
The slide lists 36 companies in the table, but the header text mentions 58 companies. The data is sourced from Capital IQ as of 4/21/2014.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
95
The table shows ranks 37-58, implying this is part of a larger list. Data source is Capital IQ.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
96
Uses a visual dot-fill system to represent high vs low value indicators.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
18
The slide highlights that peers with lower emerging market exposure and weaker brand/category positioning are still achieving 4-7% growth, contrasting with P&G's 3% growth.The Procter & Gamble Company (PG) · William Ackman
Conference presentation Activist investor Beat · Evidence & ProofLoop · The Reveal1 hit
20
The slide uses a bridge-like structure to highlight specific areas for margin expansion (Gross Margin and SG&A).The Procter & Gamble Company (PG) · William Ackman
Conference presentation Activist investor Beat · Evidence & ProofLoop · The Reveal1 hit
21
The slide uses a table to justify a higher-than-reported gross margin estimate based on segment-level analysis.The Procter & Gamble Company (PG) · William Ackman
Conference presentation Activist investor Beat · Evidence & Proof1 hit
23
The slide uses a bridge calculation to justify a margin expansion target.The Procter & Gamble Company (PG) · William Ackman
Conference presentation Activist investor Beat · Evidence & Proof1 hit
25
The slide highlights a potential efficiency gap while noting that the analysis ignores P&G's scale advantage.The Procter & Gamble Company (PG) · William Ackman
Conference presentation Activist investor Beat · Evidence & Proof1 hit
26
The slide uses a bridge-like visual to demonstrate the impact of scale on expense ratios.The Procter & Gamble Company (PG) · William Ackman
Conference presentation Activist investor Beat · Evidence & Proof1 hit
27
The slide uses a bridge-like structure to justify a margin expansion target.The Procter & Gamble Company (PG) · William Ackman
Conference presentation Activist investor Beat · Evidence & Proof1 hit
28
The slide highlights the discrepancy between revenue scale and EBIT margin parity.The Procter & Gamble Company (PG) · William Ackman
Conference presentation Activist investor Beat · Impact & Next Steps1 hit
31
The slide uses a 'bridge' logic to show the path from current performance to a target EPS.The Procter & Gamble Company (PG) · William Ackman
Conference presentation Activist investor Beat · Impact & Next Steps1 hit
34
The slide uses a table to quantify the number of external commitments to argue against the CEO's focus.The Procter & Gamble Company (PG) · William Ackman
Conference presentation Activist investor Beat · Impact & Next Steps1 hit
35
The slide uses a problem-solution mapping structure to demonstrate management's proactive response to performance issues.The Procter & Gamble Company (PG) · William Ackman
Conference presentation Activist investor Beat · Impact & Next StepsLoop · Before After1 hit
37
The slide uses a bar chart to compare P&G against a peer group consisting of Church & Dwight, Clorox, Colgate, Kimberly-Clark, L'Oréal, and Unilever.The Procter & Gamble Company (PG) · William Ackman
Conference presentation Activist investor Beat · Impact & Next StepsLoop · Before After1 hit
42
Slide 41 of a presentation. Includes footnote regarding fiscal year end and dividend assumptions.The Procter & Gamble Company (PG) · William Ackman
Conference presentation Activist investor Beat · Impact & Next Steps1 hit